Compare Dell Technologies Inc (DELL) vs Heron Therapeutics Inc (HRTX) Price & Performance

Dell Technologies IncTrade

Heron Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Dell Technologies Inc vs Heron Therapeutics Inc — how do they compare? Dell Technologies Inc trades at $451.99 (market cap $295.86B), while Heron Therapeutics Inc trades at $0.32 (market cap $63.41M). The key difference: Dell Technologies Inc is far larger — about 4665.8× Heron Therapeutics Inc's market cap, and Dell Technologies Inc pays a 0.55% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

	DELL	HRTX
Market Cap	$295.86B	$63.41M
Sector	Technology	Health
52-Week High	$467.27	$1.49
52-Week Low	$111.10	$0.32
Enterprise Value	$315.44B	$161.31M
Dividend Yield	0.55%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dell Technologies Inc

No Aura AI signal available yet.

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.

HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DELL

AI infrastructure leaders Micron, Super Micro, and Dell show strong growth and upside potential into 2027.24/7 Wall Street · 1 day agoBullish Super Micro shares rise 4% ahead of Q4 earnings on strong margin outlook and $60B backlog.24/7 Wall Street · 1 day agoBullish Super Micro Computer stock trades 21% below target amid export-control audit and $60B AI server backlog.24/7 Wall Street · 2 days agoBullish View details →

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 1 day agoBearish View details →

About Dell Technologies Inc

VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.